50 Years Ago in Biochemistry

Editor's note: Citation Classics Commentaries were written by the authors of some of the studies that were the most highly cited papers between 1961 and 1975. The essays were originally published between 1977 and 1993 in Current Contents, a publication of the Institute for Scientific Information (ISI), now Thomson Scientific. (ISI was founded by Eugene Garfield, also the founder of The Scientist.) In this essay, published in 1979, biochemist Henry Lardy recalls a 1958 paper describing his discovery of three antibiotics that could be used to study cellular respiration. One of the three antibiotics Lardy identified was oligomycin, which inhibits ATP hydrolysis. Soon after the paper was published, he became inundated with requests for the antibiotic from researchers working in the "nebulous" field of oxidative phosphorylation. According to the ISI database, the paper has been cited more than 700 times, and was the third most highly cited paper of Lardy's career. Oligomycin is still used in research, though many studies now rely on another class of antibiotics called ionophores, Lardy says. A professor emeritus at the University of Wisconsin, Madison, Lardy's current research focuses on identifying the function of naturally occurring steroids. "It's always the next experiment that's going to be the most important," he says.ºººººIn the 1950s the field of oxidative phosphorylation was so nebulous and confused that all possible concepts, facilities, and tools were needed to advance knowledge of the subject. When Hotchkiss found that gramicidin blocked phosphate uptake by Staphylococci, we had postulated that this antibiotic uncoupled phosphorylation from oxidation -- a concept we had first proposed for the metabolic effect of 2,4,-dinitrophenol (DNP).[1,2] From then on, we collected antibiotics from many sources hoping that some would be useful inhibitors of cellular respiration and phosphorylation. The first of these found to be effective was usnic acid [3] which, in micromolar concentrations, uncoupled phosphorylation in washed liver particles. We also discovered that antimycin A blocked the respiratory system of bakers yeast and enhanced aerobic fermentation to the anaerobic rate. This information was passed on to Ahmad and Strong in the next laboratory, who were working intensively on antimycin.By 1958 we had tested more than 60 antibiotics and had found about one of 10 to have interesting effects on mitochondrial metabolism and function. When we later confined our screening to antifungals that were non-toxic to anaerobic bacterial growth, one of every three or four new antibiotics was a "keeper."The 1958 paper reported the inhibition of mitochondrial respiration by oligomycin and its reversal by DNP. It inhibited ATP hydrolysis induced by DNP, Ca2 + , deoxycholate, and triiodothyroacetic acid. We concluded that oligomycin acts on an enzyme involved in phosphate fixation or in phosphate transfer rather than on enzymes in electron transport. Regardless of which theory of oxidative phosphorylation an investigator espoused, he was soon finding oligomycin useful in his work. We kept no record of the number of requests we received for this antibiotic but I know we disposed of a gross of small vials before we began folding samples into glazed paper and sending them by letter mail.Valacidin (identical with Pfizer's streptonigrin) was found to reverse respiratory inhibition by oligomycin or antimycin "indicating that it acts as an electron carrier from DPNH to cytochromes."The paper also reported for the first time the effects of nigericin and dianemycin on mitochondrial respiration, phosphorylation, and ATP hydrolysis.Dianemycin was named for Diane Johnson, the second author of the paper. She is a "classic" in her own right. After 10 years as my technician Johnson decided to take a doctorate in history of science. Although her undergraduate academic record was brilliant, as a Ph.D. candidate she suffered the disgrace of her only B grade -- in a one-credit seminar. (The professor who awarded it has since left this University and I have wondered whether he was encouraged to do so by the assistant dean of his college -- Diane Johnson.) She is also chairman of the Drug Quality Council for the State of Wisconsin -- their task, to determine whether generic drug products are equivalent to brand name products. Believe it or not, she has just been appointed assistant director of athletics at the University of Wisconsin!Bill McMurray was a postdoctorate fellow from the University of Western Ontario, where he is now professor of biochemistry and where he later discovered the effects of valinomycin on mitochondria.I have always considered this one of the trivial papers from our laboratory but am pleased that others have found it useful enough to cite it.- Henry A. Lardy, Institute for Enzyme Research, University of Wisconsin, April 12, 1978Reference: H.A. Lardy, D. Johnson, W.C. McMurray, Antibiotics as tools for metabolic studies.I. A survey of toxic antibiotics in respiratory, phosphorylative and glycolytic systems. Arch. Biochem. Biophys. 78:587-97, 1958References in essay: 1. Lardy H A and Elvehjem C A. Biological oxidations and reductions. Ann. Rev. Biochem. 14:1- 30, 1945. 2. Lardy H A and Phillips P H. The effect of thyroxine and dinitrophenol on sperm metabolism. J. Biol. Chem. 149:177-82, 1943. 3. Johnson R B, Feldott G & Lardy H A. The mode of action of the antibiotic, usnic acid. Arch. Biochem. 28:317-23, 1950.

50 Years Ago in Biochemistry

The Scientist ARCHIVES

Become a Member of

Meet the Author

Henry A. Lardy

Related Research Resources

Bunsen Burners and Bad Hair Days

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Taking the Guesswork Out of Quality Control Standards

PFAS: The Forever Chemicals

Unlocking the Unattainable in Gene Construction

Comparing Analytical Solutions for High-Throughput Drug Discovery

Products

Product News

Thermo Scientific™ Centrifuges with GreenCool Technology

Singleron Biotechnologies and Hamilton Bonaduz AG Announce the Launch of Tensor to Advance Single Cell Sequencing Automation

Zymo Research Launches Research Grant to Empower Mapping the RNome

Cytosurge Appoints Magid Haddouchi as Chief Commercial Officer